Overview

Pilot RCT Local Gentamicin for Open Tibial Fractures in Tanzania

Status:
Active, not recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Local application of antibiotics directly to the traumatic wound is a promising strategy for the prevention of infection after open tibia fractures, which are a significant source of disease burden globally, particularly in low-income countries. This pilot study aims to assess feasibility of a randomized controlled trial to measure the effect of locally applied gentamicin on risk of infection for open tibial fractures in Tanzania. If proven effective, local gentamicin would be a highly cost-effective strategy to reduce complications and disability from open tibial fractures that could impact care in both high- and low-income countries.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
Muhimbili Orthopaedic Institute
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Gentamicins